Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38-MAPK/FoxO3 pathway in cancer cachexia.
- DOI
- 10.1002/jcsm.13288
- Published
- 2023 Oct
- Container
- Journal of cachexia, sarcopenia and muscle
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/jcsm.13288,
title = {Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38-MAPK/FoxO3 pathway in cancer cachexia.},
author = {Zhang R and Shen Q and Wang Y and Deng X and Fan J and Gu X and Fan M and Wei K and Cheng CR and Zhang WD and Zhang XW and Liu X},
year = {2023},
journal = {Journal of cachexia, sarcopenia and muscle},
doi = {10.1002/jcsm.13288},
url = {https://doi.org/10.1002/jcsm.13288}
}RIS
TY - JOUR TI - Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38-MAPK/FoxO3 pathway in cancer cachexia. AU - Zhang R AU - Shen Q AU - Wang Y AU - Deng X AU - Fan J AU - Gu X AU - Fan M AU - Wei K AU - Cheng CR AU - Zhang WD AU - Zhang XW AU - Liu X PY - 2023 JO - Journal of cachexia, sarcopenia and muscle DO - 10.1002/jcsm.13288 UR - https://doi.org/10.1002/jcsm.13288 ER -
APA
R, Z., Q, S., Y, W., X, D., J, F., X, G., M, F., K, W., CR, C., WD, Z., XW, Z., & X, L. (2023). Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38-MAPK/FoxO3 pathway in cancer cachexia.. Journal of cachexia, sarcopenia and muscle. https://doi.org/10.1002/jcsm.13288
Source records
- pubmed · retrieved 2026-09-25T15:27:45.929Z